Abiopharma

🔍 Nair Syam (Executive)

Company: NetApp, Inc. (NTAP)

Report Date: 2026-08-15

Detailed Transactions and Holdings:

• Acquired 42,739 shares of Common Shares (Direct)
  Date: 2026-08-15 | Code: M | equity_swap_involved: false | shares_owned_after: 53,512.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 16,818 shares of Common Shares at $204.99 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: false | shares_owned_after: 36,694.00 | transaction_form_type: 4
• Sold 42,739 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-15 | Code: M | equity_swap_involved: false | shares_owned_after: 151,533.00 | transaction_form_type: 4 | Footnotes: F1, F1, F3, F3

Footnotes:

• F1: Restricted stock units convert into common stock on a one-for-one basis.
• F2: Reflects 379 shares purchased at $95.4295 per share under the NetApp Employee Stock Purchase Plan on May 29, 2026.
• F3: On August 15, 2025, the reporting person was granted 194,272 restricted stock units. Restricted stock unit awards shall vest as to 22% on the first anniversary, 29% on the second anniversary, 34% on the third anniversary and 15% on the fourth anniversary, subject to continued service on each applicable vesting date.